QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is Semaglutide?
Semaglutide 7mg is a high-dose oral GLP-1R agonist tablet for maximal receptor engagement in research contexts. Represents the upper range of the dose-response curve, enabling Emax determination, receptor saturation profiling, and sustained GLP-1R pathway studies. Research use only.
Research Applications
Maximum GLP-1R Engagement
Emax determination, receptor saturation, full agonist curve characterisation
High-Dose Metabolic Outcomes
Maximal insulin secretion, glucagon suppression, HbA1c-equivalent markers
Full Dose Ladder
500mcg → 3mg → 7mg semaglutide oral dose-response — complete PD profiling
Sustained GLP-1 Pathway Activation
Prolonged hypothalamic, pancreatic, and cardiac GLP-1R signalling at Emax
Oral Peptide Safety Profiling
High-dose SNAC formulation tolerability, GI biomarkers, mucosal exposure
Quick Specs
| Form | Tablet — 7mg per tablet, 25-tablet bottle |
| CAS Number | 910463-68-2 |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular Weight | ~4113.6 Da |
| Compound Type | GLP-1 Receptor Agonist (Fatty Acid-Modified) |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage | protect from moisture |
| Shelf Life | 24 months unopened |

